Oscar Health, Inc.

Hospital & Medical Service Plans

OSCRStrained6 of 10 basics passed

$33.23

+0.38%

Market cap $10.3B

$33.23

+0.38%

Market cap $10.3B

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry.

It is a $10.3B financial services company. Revenue grew 42.8% over the last year, and it keeps 4¢ of every dollar of sales as profit. It trades at 18.3× earnings — in the cheapest third of its own history.

Website: hioscar.com
Location: New York, NY
Employees: 2 305
Sector: Financial Services
Founded: 2012

Share price · 3 years

$5.32 → $33.23+524.5%

price only — dividends excluded

Key facts · TTM

Revenue: total sales; $15.3B
Profit: keeps 4¢ of every $1 sold; $551M
Free cash flow: cash left after running the business; $4.38B
Net cash: more cash than debt; $3.56B
P/E: years of profit in the price; 18.3
EPS: earnings per share, TTM; $2.10
Shares: up 47% since 2021 — dilution; 262.4M
Volatility: beta vs the market — under 1 swings less; 2.51

Revenue, last 5 years

52-week range

Low $10.85$33.23High $33.81

Today's price is 97% of the way from the year's low to its high.

P/E vs its history2y

18.7×median 135.2×

Higher than 22% of past days — in the cheapest third of its own history.

Valuation vs own history

P/E

18.7×

78%

P/S

0.7×

22%

EV/EBITDA

10.6×

70%

P/B

5.0×

FCF yield

42.5%

87%

Share of the last ~5 years that was pricier than today (in line with its own history). Based on the daily valuation record.

Standing in Financial Services

Size$10.3Btop 84%
Revenue growth+43%top 7%
Net margin4%top 87%
Return on equity39%top 7%
P/E18.3×top 66%

Ranked against 129 Financial Services companies with a full CV — for P/E, lower ranks higher.

Skills

Six independent scores, 0–100, built from reported numbers and valuation history. Click a row to see how it was scored.

Strong valuation and quality; Growth, Profitability, Health and Moat lag behind.

Valuation95

P/E vs own history22th pct · 20/25
FCF yield42.7% · 25/25
P/S0.7x · 25/25
EV/EBITDA9.8x · 25/25

Growth30

Revenue CAGR58.8% · 25/25
Net income CAGRn/a · 0/25
EPS CAGR ~5Yn/a · 0/25
Fwd implied growth4.5% · 5/25

Profitability36

ROICn/a · 0/25
ROE38.5% · 25/25
Net margin3.6% · 6/25
Operating margin4.1% · 5/25

Health25

Altman Zn/a · 0/25
Current ratio0.03 · 0/25
Interest coverage-23.8x · 0/25
Net cash / debtNet cash · 25/25

Quality77

Piotroski F5/9 · 15/25
Beneish M-3.13 · 25/25
FCF conversion795% · 25/25
Margin stabilityσ 11.3% · 12/25

Moat10

ROIC >12% yearsn/a · 0/25
Median gross marginn/a · 0/25
FCF-positive years3/5 yrs · 10/25
Worst-year net marginworst -31.1% · 0/25

How the scores work →

Experience

The company's career so far — founding, the IPO, landmark products and acquisitions, plus revenue milestones and insider buying.

FY2025Financial
Revenue crossed $10B
$11.7B for the year
FY2024Financial
Turned profitable
$25.4M net income after a loss year
FY2024Financial
Best year on record
$25.4M net income
FY2021Financial
Revenue already above $1B
$1.84B in first reported year
2012Founded
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company,…

Achievements

Verifiable track record, straight from the reported numbers.

$10 000 invested in 2021 would be worth ~$19 567 today — price return only

$11.7B revenue in FY2025

Revenue up 42.8% year over year

2 305 employees

Strengths & watch-outs

What a bull and a bear would each point to. Both lists come from the reported numbers, not opinions.

Strengths

Revenue growing 42.8% year over year
Strong cash conversion — FCF is 28.6% of revenue
Net cash position after subtracting debt from cash

Watch-outs

Thin interest coverage (-23.8×)
Loss-making in 4 of the recent years

Qualifications

The basics a company should meet before you research it further. Each check uses the reported numbers.

6 of 10 checks passed

Revenue growing — the company sells more than a year ago+42.8% YoY
Profitable — makes more than it spends$551M TTM
Profit growing — earnings are higher than last year-1842.5% YoY
Generates cash — cash left after running and investing$4.38B TTM
Debt under control — could handle its obligationsmore cash than debt
Established company — not a micro-cap — lower blow-up risk$10.3B market cap
Not printing shares — share count not ballooning — you keep your slice+46.6% shares over ~5y
Proven track record — years of profitability behind it1/5 profitable years
Financially stable — balance sheet not near distresshealth score 0/100
Pays a dividend — returns cash to shareholdersno data
Valuation not extreme — price not wildly above earningsP/E 18.3

Peer comparisonOscar Health, Inc. vs 6 largest financial services peers — cap, P/E, growth and margin side by sideOpen ▾

Company	Market cap	P/E	Revenue growth	Net margin	Profile
OSCR this company	$10.3B	18.3	+42.8%	3.6%	Strained
BRK.A Berkshire Hathaway Inc.	$1.1T	11.6	+3.9%	22.3%	Mixed
BRK.B Berkshire Hathaway	$1.1T	11.6	+0.0%	18.0%	Strong
JPM JPMorgan Chase & Co.	$886.2B	13.6	+13.5%	32.6%	Strained
V VISA Inc.	$723.9B	31.9	+14.4%	50.8%	Solid
MA Mastercard Incorporated	$516.4B	31.7	+16.0%	46.3%	Mixed
BAC Bank of America Corporation	$380.4B	11.3	+15.9%	27.8%	Mixed

Head-to-head: OSCR vs BRK.A · OSCR vs BRK.B · OSCR vs JPM

References

What covering analysts publish about the company — information only, not a recommendation.

Strong buy 2Buy 7Hold 9Sell 1

Appendix · Financial records

The full statements behind this CV, FY2021–FY2025. For readers who want to check the numbers.

Profit & lossRevenue $15.3B · net income $551M (TTM)Open ▾

Profit & loss

Revenue and profit over the company's career — the income statement, visualised.

RevenueNet income

Revenue (TTM)

$15.3B

YoY 42.8%

Net income (TTM)

$551M

Margin 3.6%

Operating margin

4.1%

P/E ratio

18.3

Income statement — full detail

Figures in USD billions · EPS in USD

	2021	2022	2023	2024	2025
Revenue	1.8	4.0	5.9	9.2	11.7
Gross profit	—	—	—	—	—
Operating income (EBIT)	-0.5	-0.6	-0.2	0.1	-0.4
Net income	-0.6	-0.6	-0.3	0.0	-0.4
EPS (diluted)	-3.20	-2.85	-1.22	0.10	-1.69

Cash flowFree cash flow $4.38B · operating cash flow $4.42B (TTM)Open ▾

Cash flow statement

Cash generated by the business and what is left after investment — year by year.

Operating cash flowFree cash flow

Free cash flow (TTM)

$4.38B

Margin 28.6%

Operating cash flow (TTM)

$4.42B

FCF margin

28.6%

Cash flow statement — full detail

Figures in USD billions

	2021	2022	2023	2024	2025
Operating cash flow	-0.2	0.4	-0.3	1.0	1.1
Capital expenditure	-0.0	-0.0	-0.0	-0.0	-0.0
Free cash flow	-0.2	0.4	-0.3	1.0	1.1
FCF margin	-11.3%	8.9%	-5.1%	10.4%	9.0%

Balance sheetAssets $6.33B · net cash $3.56B (FY2025)Open ▾

Balance sheet

How the balance sheet is built — what it owns versus how it is financed.

How $6.33B of assets is financed

85%

15%

Liabilities $5.34B — borrowed moneyEquity $978M — owners' stake

Cash vs debt

Total debt $430M − cash $3.99B = net cash $3.56B

Cash on hand covers all debt.

Debt repayment

Not needed

Cash already covers all debt

Interest coverage

-23.8x

EBIT ÷ interest expense

ROE

38.5%

Profit per $1 of equity

Balance sheet — full detail

Figures in USD billions

	2021	2022	2023	2024	2025
Cash & equivalents	1.7	3.0	2.6	2.2	4.0
Total assets	3.3	4.5	3.6	4.8	6.3
Total liabilities	1.9	3.6	2.8	3.8	5.3
Total debt	0.0	0.3	0.3	0.3	0.4
Equity	1.4	0.9	0.8	1.0	1.0
Net debt	-1.7	-2.7	-2.3	-1.9	-3.6

Want the live picture — intraday moves, valuation history and full analysis?

Deeper analysis of OSCR on PreMarketPrice

Figures are derived from company filings (quarterly values normalised from as-filed year-to-date data where applicable) and may be delayed, restated or incomplete. This page is information, not investment advice. Latest price $33.23 · market cap $10.3B.